Inhibikase Shares Shoot Higher As FDA Announced Clearance To Blood-Cell Cancer Study
August 26, 2022 at 09:16 AM EDT
The U.S. Food and Drug Administration (FDA) has reviewed Inhibikase Therapeutics’ (NASDAQ: IKT) Investigational New Drug (IND) ...